Ad is loading...
GFACX
Price
$69.11
Change
-$1.16 (-1.65%)
Updated
Nov 15 closing price
MFEIX
Price
$221.66
Change
-$4.93 (-2.18%)
Updated
Nov 15 closing price
Ad is loading...

GFACX vs MFEIX

Header iconGFACX vs MFEIX Comparison
Open Charts GFACX vs MFEIXBanner chart's image
American Funds Growth Fund of Amer C
Price$69.11
Change-$1.16 (-1.65%)
VolumeN/A
CapitalizationN/A
MFS Growth I
Price$221.66
Change-$4.93 (-2.18%)
VolumeN/A
CapitalizationN/A
GFACX vs MFEIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. MFEIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and MFEIX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 298B vs. MFEIX (47B). GFACX (0.00) and MFEIX (0.00) have matching dividends . GFACX was incepted earlier than MFEIX: GFACX (24 years) vs MFEIX (28 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. MFEIX (25.00). MFEIX has a lower initial minimum investment than GFACX: MFEIX (0) vs GFACX (250). MFEIX annual gain was more profitable for investors over the last year : 28.07 vs. GFACX (25.86). MFEIX return over 5 years is better than : 79.32 vs. GFACX (44.67).
GFACXMFEIXGFACX / MFEIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years28 years-
Gain YTD25.65528.93089%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets298B47B634%
Annual Yield % from dividends0.000.00-
Returns for 1 year25.8628.0792%
Returns for 3 years-8.399.15-92%
Returns for 5 years44.6779.3256%
Returns for 10 years54.23201.8127%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGA231.952.44
+1.06%
Reinsurance Group of America
FL23.60-0.15
-0.63%
Foot Locker
EDSA2.10-0.10
-4.55%
Edesa Biotech
EVER17.80-1.01
-5.37%
EverQuote
ADVM6.86-0.39
-5.38%
Adverum Biotechnologies